Sherry O'Quinn Email & Phone Number

Toronto, On, Ca

Toronto, Canada Area

• Partner with clients to develop reimbursement and negotiation strategies taking into account all relevant internal and external considerations. • Provide insights on pricing and market access environment opportunities and challenges with a focus on delivering market access solutions aimed at optimizing reimbursement success.• Advise clients in planning, developing and managing product listing agreement negotiations with public and private payers.• Work with clients to formulate evidence-based payer value propositions based on a comprehensive understanding of payers and their decision-making systems.• Lead policy research projects related to emerging reimbursement trends (e.g. evaluation of PLA environment, innovative agreements, international biosimilar uptake policies).• Leverage positive relationships with payers, regulators, clinicians, and patient groups to execute primary research reimbursement projects.• Participate in market access Advisory Boards to provide a former payer perspective.

Toronto - Ottawa

Led PDCI’s product listing agreement (PLA) services and related strategic reimbursement advice.

Toronto

Completed the analysis, coordinated and led negotiations of over 100 product listing agreements with manufacturers, including new listings and re-negotiations.Led the implementation of these agreements within the Ontario Public Drug Programs.Led the operational and strategic components of the brand initiative of the pan-Canadian Pharmaceutical Alliance (pCPA) in collaboration with Nova Scotia.Led 20 pCPA negotiations, chaired the bi-weekly teleconferences, managed pCPA communications.Led procurement and management of the IBM analysis on the pan-Canadian brand negotiations initiative.Worked closely with participating provinces and territories (P/Ts) in the pCPA to meet the objectives outlined by Canada’s Premiers.Fostered and maintained collaborative relationships with P/T colleagues and various external stakeholders.Acted as the key contact on product listing agreements and pCPA with the Committee to Evaluate Drugs (CED), internal Ministry staff, external stakeholders and partners.Acted as a scientific adviser to provide analytical and clinical advice to senior management, including the Assistant Deputy Minister/Executive Officer.

Responsible for managing the review of new drug submissions for reimbursement through Ontario Public Drug Programs.Responsible for the management of the Executive Officer's expert advisory committee, the Committee to Evaluate Drugs.Provide clinical leadership to senior management regarding drug related issues.Co-led the development of the Evidence Building Program with Cancer Care Ontario

Managed the review and processing of drugs submissions from drug manufacturers.Coordinated the analysis and resolution of complex and precedent-setting submission issues.Managed the support of the Drug Quality and Therapeutics Committee.Supported policy issues related to drug submissions and the Drug Quality and Therapeutics Committee.

Responsible for reviewing manufacturers' drug submissions in a consistent and timely manner.Supported the Drug Quality and Therapeutics Committee including taking accurate concise meeting minutes.Frequent correspondence with manufacturers and other stakeholders.

Mississauga, Ontario

• Developed strategic outcomes research plans for specific drug products• Ensured the timely implementation, management and completion of outcomes research studies and/or projects to support optimal levels of reimbursement• Analyzed and interpreted studies done within and outside the corporation to provide internal and external customers with relevant outcomes research information• Provided outcomes research consultancy to other functional areas in order to assist in strategic decision making and problem resolution• Monitored Canadian Health Economics requirements and the published literature to stay abreast of developments pertaining to outcomes research

Toronto

• Provided pharmaceutical care to residents of the extended care facility• Participated in a pharmacist-managed anticoagulant monitoring service• Presented inservices to nursing staff, interdisciplinary team and fellow pharmacists• Performed quarterly medication reviews• Acted as a clinical pharmacy liaison to a reactivation unit, a palliative care unit and several chronic care units • Participated in drug distribution activities in the dispensary